
Dragan Grabulovski, Araris Biotech CEO
Otsuka's Taiho buys Swiss startup Araris with three ADCs nearing the clinic
A small Swiss drug developer is being scooped up for its pipeline of three antibody-drug conjugates that offer a next-generation approach to the area of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.